Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.

Detalhes bibliográficos
Autor(a) principal: ALMEIDA, M. M. de
Data de Publicação: 2015
Outros Autores: SOUZA, Y. O. de, LUQUETTI, S. C. P. D., SABARENSE, C. M., CORRÊA, J. O. do A., CONCEIÇÃO, E. P. S. da, LISBOA, P. C., MOURA, E. G. de, SOARES, S. M. A., GUALBERTO, A. C. M., GAMEIRO, J., GAMA, M. A. S. da, LOPES, F. C. F., GARCIA, R. M. G.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
Texto Completo: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1037559
Resumo: Synthetic supplements of conjugated linoleic acid (CLA) containing 50:50 mixture of cis-9, trans-11 and trans-10, cis-12 CLA isomers have been commercialized in some places for reducing body fat. However the safety of this CLA mixture is controversial and in some countries the CLA usage as food supplement is not authorized. Changes in insulinemic control and serum lipids profile are potential negative effects related to consumption of CLA mixture. The present study aimed to evaluate the effects of a diet containing mixture of cis-9, trans-11 and trans-10, cis-12 CLA on prevention of obesity risk as well as on potential side effects such as insulin resistance and dyslipidemia in Wistar rats. Thirty male Wistar rats were randomly assigned to the following dietary treatments (n=10/group), for 60 days: Normolipidic Control (NC), diet containing 4.0% soybean oil (SO); High Fat-Control (HF-C), diet containing 24.0% SO; High Fat-synthetic CLA (HF-CLA), diet containing 1.5% of an isomeric CLA mixture (Luta-CLA 60) and 22.5% SO. Luta-CLA 60 (BASF) contained nearly 60% of CLA (cis-9, trans-11 and trans-10, cis-12 CLA at 50:50 ratio). The HF-CLA diet contained 0.3% of each CLA isomer. HF-CLA diet had no effect on dietary intake and body composition. HF-CLA-fed rats had lower levels of PPAR? protein in retroperitoneal adipose tissue, hyperinsulinemia compared to HF-C-fed rats, hyperglycemia compared to NC-fed rats while no differences in glycemia were observed between NC and HF-C groups, increased HOMA index and higher levels of serum HDL cholesterol. Thus, feeding rats with a high fat diet containing equal parts of cis-9, trans-11 and trans-10, cis-12 CLA isomers had no effect on body composition and induced insulin resistance. Despite HF-CLA-fed rats had increased serum HDL cholesterol levels, caution should be taken before synthetic supplements containing cis-9, trans-11 and trans-10, cis-12 CLA are recommended as a nutritional strategy for weight management.
id EMBR_bb41fcda8f919dcc6ed6fe184e223f49
oai_identifier_str oai:www.alice.cnptia.embrapa.br:doc/1037559
network_acronym_str EMBR
network_name_str Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
repository_id_str 2154
spelling Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.Cis-9Trans-11 CLATrans-10Cis-12 CLADyslipidemiainsulin resistanceobesitySynthetic supplements of conjugated linoleic acid (CLA) containing 50:50 mixture of cis-9, trans-11 and trans-10, cis-12 CLA isomers have been commercialized in some places for reducing body fat. However the safety of this CLA mixture is controversial and in some countries the CLA usage as food supplement is not authorized. Changes in insulinemic control and serum lipids profile are potential negative effects related to consumption of CLA mixture. The present study aimed to evaluate the effects of a diet containing mixture of cis-9, trans-11 and trans-10, cis-12 CLA on prevention of obesity risk as well as on potential side effects such as insulin resistance and dyslipidemia in Wistar rats. Thirty male Wistar rats were randomly assigned to the following dietary treatments (n=10/group), for 60 days: Normolipidic Control (NC), diet containing 4.0% soybean oil (SO); High Fat-Control (HF-C), diet containing 24.0% SO; High Fat-synthetic CLA (HF-CLA), diet containing 1.5% of an isomeric CLA mixture (Luta-CLA 60) and 22.5% SO. Luta-CLA 60 (BASF) contained nearly 60% of CLA (cis-9, trans-11 and trans-10, cis-12 CLA at 50:50 ratio). The HF-CLA diet contained 0.3% of each CLA isomer. HF-CLA diet had no effect on dietary intake and body composition. HF-CLA-fed rats had lower levels of PPAR? protein in retroperitoneal adipose tissue, hyperinsulinemia compared to HF-C-fed rats, hyperglycemia compared to NC-fed rats while no differences in glycemia were observed between NC and HF-C groups, increased HOMA index and higher levels of serum HDL cholesterol. Thus, feeding rats with a high fat diet containing equal parts of cis-9, trans-11 and trans-10, cis-12 CLA isomers had no effect on body composition and induced insulin resistance. Despite HF-CLA-fed rats had increased serum HDL cholesterol levels, caution should be taken before synthetic supplements containing cis-9, trans-11 and trans-10, cis-12 CLA are recommended as a nutritional strategy for weight management.Mariana Macedo de Almeida, UFJF; Yamara Oliveira de Souza, UFJF; Sheila Cristina Potente Dutra Luquetti, UFJF; Céphora Maria Sabarense, UFJF; José Otávio do Amaral Corrêa, UFJF; Ellen Paula Santos da Conceição, UERJ; Patrícia Cristina Lisboa, UERJ; Egberto Gaspar de Moura, UERJ; Sara Malaguti Andrade Soares, UFJF; Ana Cristina Moura Gualberto; Jacy Gameiro, UFJF; MARCO ANTONIO SUNDFELD DA GAMA, CNPGL; FERNANDO CESAR FERRAZ LOPES, CNPGL; Raúl Marcel González Garcia, UFJF.ALMEIDA, M. M. deSOUZA, Y. O. deLUQUETTI, S. C. P. D.SABARENSE, C. M.CORRÊA, J. O. do A.CONCEIÇÃO, E. P. S. daLISBOA, P. C.MOURA, E. G. deSOARES, S. M. A.GUALBERTO, A. C. M.GAMEIRO, J.GAMA, M. A. S. daLOPES, F. C. F.GARCIA, R. M. G.2016-02-18T11:11:11Z2016-02-18T11:11:11Z2016-02-1820152016-04-15T11:11:11Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleJournal of Oleo Science, v. 64, n. 5, p. 539-551, 2015.http://www.alice.cnptia.embrapa.br/alice/handle/doc/1037559porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)instname:Empresa Brasileira de Pesquisa Agropecuária (Embrapa)instacron:EMBRAPA2016-04-16T05:36:38Zoai:www.alice.cnptia.embrapa.br:doc/1037559Repositório InstitucionalPUBhttps://www.alice.cnptia.embrapa.br/oai/requestopendoar:21542016-04-16T05:36:38falseRepositório InstitucionalPUBhttps://www.alice.cnptia.embrapa.br/oai/requestcg-riaa@embrapa.bropendoar:21542016-04-16T05:36:38Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice) - Empresa Brasileira de Pesquisa Agropecuária (Embrapa)false
dc.title.none.fl_str_mv Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
title Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
spellingShingle Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
ALMEIDA, M. M. de
Cis-9
Trans-11 CLA
Trans-10
Cis-12 CLA
Dyslipidemia
insulin resistance
obesity
title_short Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
title_full Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
title_fullStr Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
title_full_unstemmed Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
title_sort Cis-9, trans-11 and trans-10, cis-12 CLA mixture does not change body composition, induces insulin resistance and increases serum HDL cholesterol level in rats.
author ALMEIDA, M. M. de
author_facet ALMEIDA, M. M. de
SOUZA, Y. O. de
LUQUETTI, S. C. P. D.
SABARENSE, C. M.
CORRÊA, J. O. do A.
CONCEIÇÃO, E. P. S. da
LISBOA, P. C.
MOURA, E. G. de
SOARES, S. M. A.
GUALBERTO, A. C. M.
GAMEIRO, J.
GAMA, M. A. S. da
LOPES, F. C. F.
GARCIA, R. M. G.
author_role author
author2 SOUZA, Y. O. de
LUQUETTI, S. C. P. D.
SABARENSE, C. M.
CORRÊA, J. O. do A.
CONCEIÇÃO, E. P. S. da
LISBOA, P. C.
MOURA, E. G. de
SOARES, S. M. A.
GUALBERTO, A. C. M.
GAMEIRO, J.
GAMA, M. A. S. da
LOPES, F. C. F.
GARCIA, R. M. G.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Mariana Macedo de Almeida, UFJF; Yamara Oliveira de Souza, UFJF; Sheila Cristina Potente Dutra Luquetti, UFJF; Céphora Maria Sabarense, UFJF; José Otávio do Amaral Corrêa, UFJF; Ellen Paula Santos da Conceição, UERJ; Patrícia Cristina Lisboa, UERJ; Egberto Gaspar de Moura, UERJ; Sara Malaguti Andrade Soares, UFJF; Ana Cristina Moura Gualberto; Jacy Gameiro, UFJF; MARCO ANTONIO SUNDFELD DA GAMA, CNPGL; FERNANDO CESAR FERRAZ LOPES, CNPGL; Raúl Marcel González Garcia, UFJF.
dc.contributor.author.fl_str_mv ALMEIDA, M. M. de
SOUZA, Y. O. de
LUQUETTI, S. C. P. D.
SABARENSE, C. M.
CORRÊA, J. O. do A.
CONCEIÇÃO, E. P. S. da
LISBOA, P. C.
MOURA, E. G. de
SOARES, S. M. A.
GUALBERTO, A. C. M.
GAMEIRO, J.
GAMA, M. A. S. da
LOPES, F. C. F.
GARCIA, R. M. G.
dc.subject.por.fl_str_mv Cis-9
Trans-11 CLA
Trans-10
Cis-12 CLA
Dyslipidemia
insulin resistance
obesity
topic Cis-9
Trans-11 CLA
Trans-10
Cis-12 CLA
Dyslipidemia
insulin resistance
obesity
description Synthetic supplements of conjugated linoleic acid (CLA) containing 50:50 mixture of cis-9, trans-11 and trans-10, cis-12 CLA isomers have been commercialized in some places for reducing body fat. However the safety of this CLA mixture is controversial and in some countries the CLA usage as food supplement is not authorized. Changes in insulinemic control and serum lipids profile are potential negative effects related to consumption of CLA mixture. The present study aimed to evaluate the effects of a diet containing mixture of cis-9, trans-11 and trans-10, cis-12 CLA on prevention of obesity risk as well as on potential side effects such as insulin resistance and dyslipidemia in Wistar rats. Thirty male Wistar rats were randomly assigned to the following dietary treatments (n=10/group), for 60 days: Normolipidic Control (NC), diet containing 4.0% soybean oil (SO); High Fat-Control (HF-C), diet containing 24.0% SO; High Fat-synthetic CLA (HF-CLA), diet containing 1.5% of an isomeric CLA mixture (Luta-CLA 60) and 22.5% SO. Luta-CLA 60 (BASF) contained nearly 60% of CLA (cis-9, trans-11 and trans-10, cis-12 CLA at 50:50 ratio). The HF-CLA diet contained 0.3% of each CLA isomer. HF-CLA diet had no effect on dietary intake and body composition. HF-CLA-fed rats had lower levels of PPAR? protein in retroperitoneal adipose tissue, hyperinsulinemia compared to HF-C-fed rats, hyperglycemia compared to NC-fed rats while no differences in glycemia were observed between NC and HF-C groups, increased HOMA index and higher levels of serum HDL cholesterol. Thus, feeding rats with a high fat diet containing equal parts of cis-9, trans-11 and trans-10, cis-12 CLA isomers had no effect on body composition and induced insulin resistance. Despite HF-CLA-fed rats had increased serum HDL cholesterol levels, caution should be taken before synthetic supplements containing cis-9, trans-11 and trans-10, cis-12 CLA are recommended as a nutritional strategy for weight management.
publishDate 2015
dc.date.none.fl_str_mv 2015
2016-02-18T11:11:11Z
2016-02-18T11:11:11Z
2016-02-18
2016-04-15T11:11:11Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv Journal of Oleo Science, v. 64, n. 5, p. 539-551, 2015.
http://www.alice.cnptia.embrapa.br/alice/handle/doc/1037559
identifier_str_mv Journal of Oleo Science, v. 64, n. 5, p. 539-551, 2015.
url http://www.alice.cnptia.embrapa.br/alice/handle/doc/1037559
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
instname:Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron:EMBRAPA
instname_str Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron_str EMBRAPA
institution EMBRAPA
reponame_str Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
collection Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
repository.name.fl_str_mv Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice) - Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
repository.mail.fl_str_mv cg-riaa@embrapa.br
_version_ 1794503418099793920